JP2005524629A - 体重、血中脂質レベルを減少させるため、並びに癌の予防および治療のためのホホバ製品 - Google Patents

体重、血中脂質レベルを減少させるため、並びに癌の予防および治療のためのホホバ製品 Download PDF

Info

Publication number
JP2005524629A
JP2005524629A JP2003563522A JP2003563522A JP2005524629A JP 2005524629 A JP2005524629 A JP 2005524629A JP 2003563522 A JP2003563522 A JP 2003563522A JP 2003563522 A JP2003563522 A JP 2003563522A JP 2005524629 A JP2005524629 A JP 2005524629A
Authority
JP
Japan
Prior art keywords
jojoba
fat
simmondsin
reducing composition
donation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003563522A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005524629A5 (enExample
Inventor
ワン，イービン
ワン，イーホン
レイリー，ピーター
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arizona Health Consulting Group LLC
Original Assignee
Arizona Health Consulting Group LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arizona Health Consulting Group LLC filed Critical Arizona Health Consulting Group LLC
Publication of JP2005524629A publication Critical patent/JP2005524629A/ja
Publication of JP2005524629A5 publication Critical patent/JP2005524629A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2003563522A 2002-02-01 2003-01-31 体重、血中脂質レベルを減少させるため、並びに癌の予防および治療のためのホホバ製品 Pending JP2005524629A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6616402A 2002-02-01 2002-02-01
US10/212,577 US7138134B2 (en) 2001-12-18 2002-08-05 Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels
PCT/US2003/003013 WO2003063828A1 (en) 2002-02-01 2003-01-31 Jojoba product for reducing weight, blood lipid levels and for the prevention and treatment of cancer

Publications (2)

Publication Number Publication Date
JP2005524629A true JP2005524629A (ja) 2005-08-18
JP2005524629A5 JP2005524629A5 (enExample) 2006-03-09

Family

ID=27667789

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003563522A Pending JP2005524629A (ja) 2002-02-01 2003-01-31 体重、血中脂質レベルを減少させるため、並びに癌の予防および治療のためのホホバ製品

Country Status (4)

Country Link
US (2) US7138134B2 (enExample)
EP (1) EP1480613A1 (enExample)
JP (1) JP2005524629A (enExample)
WO (1) WO2003063828A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060105066A1 (en) * 2003-07-22 2006-05-18 Avoca, Inc. Compounds for altering food intake in humans
WO2005035793A2 (en) * 2003-10-09 2005-04-21 Decode Genetics Ehf. Cckar markers and haplotypes associated with extreme weight conditions
EP1616874A1 (en) * 2004-07-14 2006-01-18 Universiteit Gent Mono- and bicyclic compounds with therapeutic activity and pharmaceutical compositions including them
JP2007045814A (ja) * 2005-07-11 2007-02-22 Eisai Food Chemical Kk コレステロール調節剤
US7850997B2 (en) * 2007-03-21 2010-12-14 Tim Romero Dietary compositions and methods of enhancing lean body mass and exercise performance
US9180154B2 (en) * 2009-11-05 2015-11-10 Arizona Health Consulting Group, Llc Method of manufacturing magnoliidae compounds
WO2018178970A1 (en) * 2017-03-26 2018-10-04 Minovia Therapeutics Ltd. Mitochondrial compositions and methods for treatment of skin and hair
EP3823646A4 (en) 2018-07-22 2022-06-08 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of brain diseases
WO2020021535A1 (en) 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of ocular diseases
US12329781B2 (en) 2018-07-22 2025-06-17 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of renal diseases
WO2023164661A1 (en) * 2022-02-25 2023-08-31 The Trustees Of Columbia University In The City Of New York Alteration of nutrient preferences via modulation of nutrient receptors in the gut
CN117958446B (zh) 2024-03-28 2024-07-05 北京衡美金叶营养健康科技有限公司 一种减重降体脂的组合物、制备方法及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1006958A3 (nl) 1993-04-29 1995-01-31 Ku Leuven Research & Dev Vzw Werkwijze voor het beinvloeden van de voedselopname door mensen en dieren.
US5626849A (en) * 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
US5998457A (en) * 1995-10-26 1999-12-07 Avicena Group, Inc. Creatine analogues for treatment of obesity
US6245364B1 (en) * 1996-02-29 2001-06-12 International Flora Technologies, Ltd. Weight reduction method for cats and other pets
US5962043A (en) * 1996-02-29 1999-10-05 Seal Rock Technologies Incorporated Weight reduction method for dogs and other pets
JP2002516828A (ja) * 1998-06-01 2002-06-11 アンソニー・ジェイ・バービスカー 局所経皮治療
US20050203187A1 (en) * 1998-06-01 2005-09-15 Verbiscar Anthony J. Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof
US6007823A (en) * 1998-06-02 1999-12-28 The United States Of America As Represented By The Secretary Of Agriculture Simmondsin concentrate from jojoba
US6451986B1 (en) * 1998-06-22 2002-09-17 Immunex Corporation Site specific protein modification
US6746695B1 (en) * 1998-10-02 2004-06-08 Armadillo Pharmaceuticals, Inc. Pharmaceutical preparations of bioactive substances extracted from natural sources
US6531114B1 (en) * 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
JP2003500452A (ja) 1999-05-27 2003-01-07 アーマディーロ・ファーマシューティカルス・インコーポレーテッド 天然資源から抽出した生物活性物質の医薬製剤
US6277842B1 (en) * 2000-10-17 2001-08-21 James Alexander Carthron Dietary supplemental method for fat and weight reduction
US6552171B2 (en) * 2001-04-23 2003-04-22 Midwest Grain Products Hydrolyzed jojoba protein
TNSN02063A1 (en) * 2001-07-07 2005-12-23 Egyptian Natural Oil Co Natoil The medical effect of jojoba oil
US6852342B2 (en) * 2002-03-26 2005-02-08 Avoca, Inc. Compounds for altering food intake in humans

Also Published As

Publication number Publication date
US20070026091A1 (en) 2007-02-01
EP1480613A1 (en) 2004-12-01
US7138134B2 (en) 2006-11-21
US20030113389A1 (en) 2003-06-19
WO2003063828A1 (en) 2003-08-07
US8673343B2 (en) 2014-03-18

Similar Documents

Publication Publication Date Title
JPH11500725A (ja) ピペリンのバイオアベイラビリティ増強剤としての使用
TW200410680A (en) Nutritiona compositions
AU3666497A (en) Appetite suppression
CN101460159B (zh) 疲劳缓解剂
WO2007053846A1 (en) Compositions of hoodia gordonii and pinolenic acid derivatives
US7138134B2 (en) Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels
CA2890386C (en) Blood flow promoting agent
WO2004091368A2 (en) Sea buckthorn compositions and associated methods
EP1083915A1 (en) Compositions and methods for enhancing protein anabolism and detoxification
JP2006182679A (ja) ストレス性胃炎予防・治療剤
JP2019182881A (ja) 末梢神経障害の予防又は改善用組成物
ES2747932T3 (es) Uso de fitoecdisonas en la preparación de una composición para actuar sobre el síndrome metabólico
JP2014524743A (ja) 多成分栄養系
WO2013067485A1 (en) Nutritional supplement for weight management
WO2019146735A1 (ja) 侵害受容性疼痛の予防又は改善用組成物
US20100323031A1 (en) Synergistic combination to enhance blood glucose and insulin metabolism
JP3634721B2 (ja) 高脂血症の予防又は治療剤
CA2637243C (en) Novel use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product
RU2636471C1 (ru) Биологически активная добавка, обладающая седативно-антидепрессивным действием
KR100441308B1 (ko) 다이어트 인삼복합음료 및 그 제조방법
US20150306182A1 (en) Fat loss composition
CA2174348A1 (en) Methodologies for extracting and using muira puama
Lucy et al. Complementary and alternative therapies for obesity
US20210346334A1 (en) Nutritional chromium compositions and methods of use
US20110104310A1 (en) Method of Manufacturing Magnoliidae Compounds

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060123

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060123

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090825

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091125

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091222